Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PharmStar, a US based drug development, manufacturing and marketing company, has appointed Howard Phykitt as the new CEO and the chairman of the board of directors.
Subscribe to our email newsletter
Phykitt has spent 17 years researching, testing, patenting and developing Aquaprin, PharmStar’s FDA-approved over-the-counter (OTC) liquid pain reliever.
Phykitt has developed a granulation and coating technology in 1970s, that is in use by Eli Lily, Glaxo Smithkline and others in the manufacturing of a litany of pharmaceutical products today.
He founded Granutec in 1984, where he developed fluid bed micro-encapsulation for use in the pharmaceutical and agriculture industries.